[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].
Miller, K
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. [electronic resource] - Aktuelle Urologie Jan 2009 - 27-30 p. digital
Publication Type: Comparative Study; Consensus Development Conference; Journal Article
1438-8820
10.1055/s-0028-1098786 doi
Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--administration & dosage
Benzenesulfonates--administration & dosage
Bevacizumab
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Humans
Indoles--administration & dosage
Kidney--pathology
Kidney Neoplasms--drug therapy
Neoadjuvant Therapy
Neoplasm Metastasis
Nephrectomy
Niacinamide--analogs & derivatives
Phenylurea Compounds
Protein Kinase Inhibitors--administration & dosage
Pyridines--administration & dosage
Pyrroles--administration & dosage
Risk Assessment
Risk Factors
Sirolimus--administration & dosage
Sorafenib
Sunitinib
Time Factors
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]. [electronic resource] - Aktuelle Urologie Jan 2009 - 27-30 p. digital
Publication Type: Comparative Study; Consensus Development Conference; Journal Article
1438-8820
10.1055/s-0028-1098786 doi
Angiogenesis Inhibitors--administration & dosage
Antibodies, Monoclonal--administration & dosage
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--administration & dosage
Benzenesulfonates--administration & dosage
Bevacizumab
Carcinoma, Renal Cell--drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Humans
Indoles--administration & dosage
Kidney--pathology
Kidney Neoplasms--drug therapy
Neoadjuvant Therapy
Neoplasm Metastasis
Nephrectomy
Niacinamide--analogs & derivatives
Phenylurea Compounds
Protein Kinase Inhibitors--administration & dosage
Pyridines--administration & dosage
Pyrroles--administration & dosage
Risk Assessment
Risk Factors
Sirolimus--administration & dosage
Sorafenib
Sunitinib
Time Factors